Paper Details

  1. Home
  2. Paper Details

Psychedelics in the treatment of unipolar and bipolar depression.

Author: BoschOliver G, HalmSimon, SeifritzErich

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This narrative review explores the potential of classic and atypical psychedelics in treating unipolar and bipolar depression. While classic psychedelics like psilocybin show promising efficacy, they may also induce mania. Atypical psychedelics like MDMA and ketamine are also being explored for their therapeutic potential in depression. Further research is needed to determine the effectiveness and safety of these substances in clinical settings.
Paper Details　
Original Abstract of the Article :
This is a narrative review about the role of classic and two atypical psychedelics in the treatment of unipolar and bipolar depression. Since the 1990s, psychedelics experience a renaissance in biomedical research. The so-called classic psychedelics include lysergic acid diethylamide (LSD), psilocyb...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256889/

データ提供：米国国立医学図書館（NLM）

Psychedelics: A New Frontier in Depression Treatment?

The search for effective treatments for depression is an ongoing pursuit in the field of mental health. This study examines the potential of classic and atypical psychedelics in the treatment of both unipolar and bipolar depression. The researchers provide a narrative review of the emerging research on psychedelics, highlighting their potential therapeutic value and the evolving paradigm of psychedelic-assisted psychotherapy.

A New Paradigm: Psychedelic-Assisted Psychotherapy for Depression

The study explores the potential of psychedelics, particularly psilocybin and ketamine, in treating depression. The research suggests that psychedelic-assisted psychotherapy, a therapeutic framework that integrates psychedelic experiences with ongoing psychotherapy, holds promise for treating various forms of depression.

Exploring Uncharted Territories: Dr. Camel's Perspective

This research delves into the intriguing world of psychedelics and their potential in treating depression. Like a camel venturing into uncharted desert landscapes, researchers are exploring new avenues for treating mental illness.

Dr. Camel's Conclusion

This review highlights the emerging research on the potential of psychedelics in treating depression. The study emphasizes the need for rigorous clinical trials to fully understand the efficacy and safety of psychedelic-assisted psychotherapy.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

35788817

DOI: Digital Object Identifier

PMC9256889

Related Literature

Article Analysis
・Effects of esketamine nasal spray
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.